CORV - Correvio Pharma Corp. (CORV) CEO Dr. Bill Hunter on Q4 2018 Results - Earnings Call Transcript
Correvio Pharma Corp. (CORV)
Q4 2018 Results Earnings Conference Call
March 13, 2019 08:00 AM ET
Company Participants
Justin Renz - Chief Financial Officer
Dr. Bill Hunter - President and CEO
Dr. Mark Corrigan - Incoming CEO
David Dean - Chief Business Development Officer
Conference Call Participants
Dewey Steadman - Canaccord
Swayampakula Ramakanth - H.C. Wainwright
PJ Solit - Potomac Capital
Presentation
Operator
Good afternoon, ladies and gentlemen, and welcome to Correvio's Fourth Quarter and Year-End 2018 Financial Results Conference Call. There will be a question-and-answer session to follow. Please be advised that this call